Showing results (191-200 of 284) with videos related to
Sort By:
Pageof 29
Gynecologic Oncology|April 29, 2000
The diagnostic value of power Doppler measurements in the endometrium of women with postmenopausal bleedingA Amit, Z Weiner, N Ganem, et al.Gynecologic Oncology|May 1, 1986
A phase II trial of 4-demethoxydaunorubicin in refractory epithelial ovarian cancerJ J Kavanagh, L J Copeland, D M Gershenson, et al.European Journal of Gynaecological Oncology|January 1, 1997
Prolonged oral etoposide for advanced uterine leiomyosarcoma with pulmonary metastases: case reportW Termrungruanglert, A P Kudelka, S Piamsomboon, et al.Gynecologic Oncology|September 1, 1994
MRI of recurrent cystic mesothelioma: differential diagnosis of cystic pelvic massesJ A Romero, E E Kim, A P Kudelka, et al.Cancer Research|January 1, 1997
Identification of naturally processed human ovarian peptides recognized by tumor-associated CD8+ cytotoxic T lymphocytesB Fisk, B W Anderson, K R Gravitt, et al.International Journal of Cancer|November 15, 1983
Estrogen and progesterone receptor titers in primary epithelial ovarian carcinomasL A Jones, C L Edwards, R S Freedman, et al.Lymphokine Research|January 1, 1989
Lymphokine activity in malignant effusions after intracavitary viral oncolysateR S Freedman, N M Kouttab, J M Bowen, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1995
Effects of interleukin-1 alpha administration on pituitary-adrenal and pituitary-thyroid axes function of patients with ovarian cancerR Vassilopoulou-Sellin, A P Kudelka, J J Kavanagh, et al.European Journal of Gynaecological Oncology|January 1, 1996
A case report of paclitaxel administered to a patient with platinum-refractory ovarian cancer on long-term hemodialysisO Balat, A P Kudelka, C L Edwards, et al.Gynecologic Oncology|October 1, 1992
The effect of prolonged cisplatin-based chemotherapy on progression-free survival in patients with optimal epithelial ovarian cancer: "maintenance" therapy reconsideredD M Gershenson, M F Mitchell, N Atkinson, et al.Pageof 29